Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jonathan Goldin

Diagnostic Radiology Los Angeles, CA Medical Doctor

NPI 1477502144 CMS profile 112456

757 Westwood Plz Ste 1501, Los Angeles, CA 90095

Open in the dashboard

General payments

$167,615

176 records reported · program years 2019–2025

Research payments

$4,717

Paid to them · 9 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$200,599 paid to institutions, not to them · program year 2019

Through program year 2025, Jonathan Goldin of Los Angeles, CA is reported in the CMS Open Payments database as having received $167,615 across 176 general payments and $4,717 in research payments paid to them. Separately, studies naming them as principal investigator received $200,599 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,317 31
2024 General $12,613 9
2023 General $11,622 30
2022 General $22,295 29
2021 General $9,958 5
2020 General $15,857 7
2020 Research $3,233 1
2019 General $85,953 65
2019 Research $1,484 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jonathan Goldin
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Jonathan Goldin were reported at $9,317. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Jonathan Goldin Diagnostic Radiology median Middle half National median
2019 $85,953 $108 $29–$318 $163
2020 $15,857 $65 $21–$252 $114
2021 $9,958 $92 $24–$292 $132
2022 $22,295 $104 $29–$294 $149
2023 $11,622 $110 $29–$337 $160
2024 $12,613 $113 $30–$356 $164
2025 $9,317 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $84,896 45 payments
  2. Siemens Medical Solutions USA, Inc. $38,006 98 payments
  3. Genentech USA, Inc. $31,765 17 payments
  4. Olympus Corporation of the Americas $9,322 10 payments
  5. Boehringer Ingelheim Taiwan Ltd. $2,100 1 payment
  6. Servier Pharmaceuticals LLC $800 1 payment
  7. E.R. Squibb & Sons, L.L.C. $650 1 payment
  8. Carestream Health, Inc. $37 1 payment
  9. Ge Healthcare $23 1 payment
  10. Exelixis Inc. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $75,350 12 payments
  2. Travel and Lodging $44,327 67 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $34,176 16 payments
  4. Education $9,322 10 payments
  5. Food and Beverage $3,640 70 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $800 1 payment
Products named General payments · program years 2019–2025
  1. OFEV Respiratory $30,598 25 payments
  2. MAGNETOM Vida $17,061 37 payments
  3. OFEV Respiratory $14,635 9 payments
  4. MAGNETOM Vida 3T $9,406 2 payments
  5. Olympus Capital Accessories $9,322 10 payments
  6. Olympus Respiratory Accessories $9,322 10 payments
  7. Olympus Bronchoscopes $7,268 6 payments
  8. Olympus EBUS Bronchoscopes $6,794 6 payments
  9. MAGNETOM Free.Max $1,705 28 payments
  10. NAEOTOM Alpha $1,649 17 payments
  11. Other $2,102 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. F. Hoffmann-La Roche AG $4,717 9 payments

Billing to Medicare

Part B · data year 2024 · 13 billing codes

Paid by Medicare

$117,757

Of which drugs: $433

Medicare patients

133

Average age 77

Services billed

4,424

72 women, 61 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 66%
Cancer 49%
Arthritis 49%
Ischemic heart disease 39%
Chronic kidney disease 38%
Diabetes 33%
Depression 27%
Atrial fibrillation 25%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 41 4,060 $433

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
OFEV
  • Boehringer Ingelheim Pharmaceuticals, Inc. $12,535
$12,535 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

185 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record